IART — Integra LifeSciences Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $2.23bn
- $3.42bn
- $1.54bn
- 72
- 65
- 27
- 54
Annual cashflow statement for Integra LifeSciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 50.2 | 134 | 169 | 181 | 67.7 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 105 | 59.4 | 8.11 | 9.63 | 42.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -14.5 | -41.3 | 18.2 | -39.4 | -81.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 231 | 204 | 312 | 264 | 140 |
| Capital Expenditures | -135 | -63.9 | -48.1 | -47.1 | -66.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -28.1 | -4.18 | -113 | -11.5 | -27.3 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -163 | -68.1 | -161 | -58.6 | -94.2 |
| Financing Cash Flow Items | -6.51 | -29.4 | -5.05 | -24.6 | -13.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -8.77 | 122 | -98.2 | -252 | -230 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 60.1 | 271 | 43.3 | -56.8 | -180 |